Core Insights - MDB Capital Holdings, LLC is focused on launching category-leading "Big Idea" companies in public markets, aiming to provide investors with new opportunities as traditional venture and private equity markets undergo restructuring [3][5]. Operational Highlights - For the second quarter of 2025, MDB Capital has launched a private offering for Paulex Bio, which is developing a medication targeting the root cause of diabetes [8]. - The company announced its next IPO and filed an S-1 for Buda Juice, which is innovating in the fresh juice category with its UltraFresh™ cold-crafted juices [8]. - MDB Capital has deepened its pipeline of early-stage, disruptive companies that have the potential to become leaders in new categories [8]. - A strategic partnership with Keiretsu Forum MST was announced to drive IPO Angels, expanding MDB's investor community [8]. - The company is broadening relationships with Registered Investment Advisors (RIAs) to attract new investors with large equity portfolios seeking venture exposure [8]. - Plans to spin out PatentVest, an IP law firm, as an independent public company in 2026 were also announced, aiming to leverage this unique asset for value creation [8].